Calculates Candida Score for non-neutropenic ICU patients to guide empiric antifungal therapy, and determines echinocandin dosing and step-down azole criteria based on Candida species identification.
BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).
BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.
Calculates Candida Score for non-neutropenic ICU patients to guide empiric antifungal therapy, and determines echinocandin dosing and step-down azole criteria based on Candida species identification
Each component has a specific meaning:
Note: Interpret the candidemia risk result against the clinical thresholds and context described above.
Enter the Candida species identification for the patient or scenario you are assessing. Calculates Candida Score for non-neutropenic ICU patients to guide empiric antifungal therapy, and determines echinocandin dosing and step-down azole criteria based on Candida species identification. Use the candidemia risk result to inform your clinical assessment.